Research advances in intracerebral hemorrhage complicating human immunodeficiency virus infection

doi:10.3877/cma.j.issn.1673-9248.2025.03.013

Abstract

Abstract:

With the widespread application of antiretroviral therapy, the life expectancy of individuals infected with the human immunodeficiency virus (HIV) has significantly increased. Against this backdrop, non-communicable diseases—particularly intracerebral hemorrhage (ICH)—have emerged as a key focus of research. Current studies indicate a strong association between HIV infection and ICH, highlighting the elevated mortality risk in HIV-infected patients who develop ICH. Therefore, this review synthesizes recent advances in epidemiological trends, pathological mechanisms, risk factors, clinical phenotypes, and therapeutic strategies related to HIV-associated ICH.

Key words: Human immunodeficiency virus, Intracerebral hemorrhage, Risk factors, Pathogenesis, Therapeutic strategy

Qiuhui Huang, Zhijian Liang. Research advances in intracerebral hemorrhage complicating human immunodeficiency virus infection[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2025, 19(03): 255-259.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnxgbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9248.2025.03.013

https://zhnxgbzz.cma-cmc.com.cn/EN/Y2025/V19/I03/255

References 47

1	Pinto AN. AIDS and cerebrovascular disease[J]. Stroke, 1996, 27(3): 538-543.
2	Moawad M, Mohamed Shalaby MM, Hamouda E, et al. Risk of stroke among HIV patients: a systematic review and meta-analysis of global studies and associated comorbidities[J]. J Acquir Immune Defic Syndr, 2024, 95(5): 399-410.
3	Mbonde AA, Chang J, Musubire A, et al. An analysis of stroke risk factors by HIV serostatus in Uganda: implications for stroke prevention in Sub-Saharan Africa[J]. J Stroke Cerebrovasc Dis, 2022, 31(7): 106449.
4	Abdallah A, Chang JL, O'Carroll CB, et al. Validation of the intracerebral hemorrhage score in Uganda[J]. Stroke, 2018, 49(12): 3063-3066.
5	Chow FC, He W, Bacchetti P, et al. Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort[J]. Neurology, 2014, 83(19): 1705-1711.
6	Patel UK, Malik P, Li Y, et al. Stroke and HIV-associated neurological complications: a retrospective nationwide study[J]. J Med Virol, 2021, 93(8): 4915-4929.
7	Du M, Wang Y, Qin C, et al. Prevalence and incidence of stroke among people with HIV[J]. AIDS, 2023, 37(11): 1747-1756.
8	Prakash P, Swami Vetha BS, Chakraborty R, et al. HIV-associated hypertension: risks, mechanisms, and knowledge gaps[J]. Circ Res, 2024, 134(11): e150-e175.
9	Durand M, Sheehy O, Baril JG, et al. Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study[J]. J Stroke Cerebrovasc Dis, 2013, 22(7): e34-41.
10	Peng J, Wang H, Rong X, et al. Cerebral hemorrhage and alcohol exposure: a review[J]. Alcohol Alcohol, 2020, 55(1): 20-27.
11	Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar[J]. J Am Coll Cardiol, 2020, 75(15): 1804-1818.
12	Chow FC, Ma Y, Manion M, et al. Factors associated with worse cerebrovascular function in aging women with and at risk for HIV[J]. AIDS, 2021, 35(2): 257-266.
13	Chow FC, Nance RM, Becker K, et al. Sex differences in the risk of stroke associated with traditional and non-traditional factors in a US cohort of people with HIV infection[J]. Neurology, 2024, 103(4): e209726.
14	Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association[J]. Circulation, 2019, 140(2): e98-e124.
15	Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management[J]. Nat Rev Cardiol, 2019, 16(12): 745-759.
16	Ruamtawee W, Tipayamongkholgul M, Aimyong N, et al. Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review[J]. BMC Public Health, 2023, 23(1): 477.
17	Mokoena H, Mabhida SE, Choshi J, et al. Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: a systematic review of clinical studies[J]. Atheroscler Plus, 2024, 55: 47-54.
18	Ku HC, Wu YL, Yip HT, et al. Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case-control study[J]. BMC Infect Dis, 2023, 23(1): 636.
19	Castillo-Mancilla JR, Cavassini M, Schneider MP, et al. Association of incomplete adherence to antiretroviral therapy with cardiovascular events and mortality in virologically suppressed persons with HIV: the Swiss HIV cohort study[J]. Open Forum Infect Dis, 2021, 8(2): ofab032.
20	Chow FC, Li Y, Hu Y, et al. Relationship between HIV infection, antiretroviral therapy, inflammatory markers, and cerebrovascular endothelial function among adults in Urban China[J]. J Acquir Immune Defic Syndr, 2017, 74(3): 339-346.
21	Benjamin LA, Corbett EL, Connor MD, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: a case-control study[J]. Neurology, 2016, 86(4): 324-333.
22	Zimba S, Nutakki A, Chishimba L, et al. Risk factors and outcomes of HIV-associated stroke in Zambia[J]. AIDS, 2021, 35(13): 2149-2155.
23	Global Burden of Disease Cancer C, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2019, 5(12): 1749-1768.
24	Sadiq E, Katzew S, Nel J, et al. Stroke, HIV and the immune reconstitution inflammatory syndrome in the absence of opportunistic infections[J]. J Neurol Sci, 2024, 457: 122880.
25	Weber M, Duran Ramirez JJ, Hentzien M, et al. Time trends in causes of death in people with HIV: insights from the Swiss HIV cohort study[J]. Clin Infect Dis, 2024, 79(1): 177-188.
26	Suligoi B, Virdone S, Taborelli M, et al. Excess mortality related to circulatory system diseases and diabetes mellitus among Italian AIDS patients vs. non-AIDS population: a population-based cohort study using the multiple causes-of-death approach[J]. BMC Infect Dis, 2018, 18(1): 428.
27	Cruse B, Cysique LA, Markus R, et al. Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy[J]. J Neurovirol, 2012, 18(4): 264-276.
28	Sugiyama K, Watanuki H, Tochii M, et al. Impact of postoperative cerebral complications in acute infective endocarditis: a retrospective single-center study[J]. J Cardiothorac Surg, 2024, 19(1): 254.
29	Hauer L, Pikija S, Schulte EC, et al. Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review[J]. J Neuroinflammation, 2019, 16(1): 19.
30	Hu Z, Deng X, Zhou S, et al. Pathogenic mechanisms and therapeutic implications of extracellular matrix remodelling in cerebral vasospasm[J]. Fluids Barriers CNS, 2023, 20(1): 81.
31	Vinikoor MJ, Napravnik S, Floris-Moore M, et al. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States[J]. AIDS Res Hum Retroviruses, 2013, 29(7): 1068-1074.
32	Hatleberg CI, Ryom L, Kamara D, et al. D: A: D Study Group. Predictors of ischemic and hemorrhagic strokes among people living with HIV: the D: A: D International Prospective Multicohort Study[J]. EClinicalMedicine, 2019, 13: 91-100.
33	Hernandez Fustes OJ, Arteaga Rodriguez C. Neurological manifestations of acquired immunodeficiency syndrome[J]. Cureus, 2020, 12(9): e10449.
34	Thakur KT, Lyons JL, Smith BR, et al. Stroke in HIV-infected African Americans: a retrospective cohort study[J]. J Neurovirol, 2016, 22(1): 50-55.
35	Theofilis P, Vordoni A, Koukoulaki M, et al. Overview of infections as an etiologic factor and complication in patients with vasculitides[J]. Rheumatol Int, 2022, 42(5): 759-770.
36	Vega LE, Espinoza LR. Vasculitides in HIV infection[J]. Curr Rheumatol Rep, 2020, 22(10): 60.
37	Gutierrez J, Ortiz G. HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series[J]. Clin Neuroradiol, 2011, 21(3): 145-151.
38	Takayama M, Kashiwagi M, Matsusue A, et al. An autopsy case of cerebral hemorrhage in an HIV-infected patient with suspected HIV-associated cerebrovascular disease[J]. J Forensic Leg Med, 2024, 103: 102672.
39	Ferfar Y, Savey L, Comarmond C, et al. Large-vessel vasculitis in human immunodeficiency virus-infected patients[J]. J Vasc Surg, 2018, 67(5): 1501-1511.
40	Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma[J]. Hum Pathol, 2000, 31(3): 374-379.
41	Saadoun D, Vautier M, Cacoub P. Medium- and large-vessel vasculitis[J]. Circulation, 2021, 143(3): 267-282.
42	White EI, Anand P, Cervantes-Arslanian AM. Characteristics and evolution of cerebral aneurysms among adults living with HIV: a retrospective, longitudinal case series[J]. J Stroke Cerebrovasc Dis, 2023, 32(6): 107127.
43	Filipkowski AM, Kundu S, Eden SK, et al. Association of HIV infection and incident abdominal aortic aneurysm among 143 001 veterans[J]. Circulation, 2023, 148(2): 135-143.
44	Gutierrez J, Elkind MS, Petito C, et al. The contribution of HIV infection to intracranial arterial remodeling: a pilot study[J]. Neuropathology, 2013, 33(3): 256-263.
45	Benjamin L, Khoo S. HIV infection and stroke[J]. Handb Clin Neurol, 2018, 152: 187-200.
46	Roquer J, Palomeras E, Knobel H, et al. Intracerebral haemorrhage in AIDS[J]. Cerebrovasc Dis, 1998, 8(4): 222-227.
47	Kucab P, Bhattacharya P. Epidemiology of acquired immune deficiency syndrome and cerebrovascular disease in a post antiretroviral era[J]. J Stroke Cerebrovasc Dis, 2017, 26(6): 1197-1203.

[1]	Xiaolu Zhu, Xixi Sun, Jiayuan Chai, Zeyang Dong, Mengyao Zhao, Bin Huang. Analysis of factors associated with ineffectiveness of ultrasound-guided medical anhydrous ethanol sclerotherapy for ovarian endometriotic cysts [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(03): 215-223.
[2]	Peizhen Li, Hailiang Liu, Dawei Li, Hao Jia, Zejin Zhang, Liwei Liu, Shen Chuan'an Shen. Analysis of risk factors for early acute kidney injury in patients with severe burns and establishment of a prediction model [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2025, 20(03): 199-205.
[3]	Xue Zhang, Zhengchao Chen, Yichen Li, Hui He, Kaibo Liu. Analysis on the effectiveness of interventions to prevent mother-to-child transmission in 10 250 children exposed to hepatitis B virus vertical transmission [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2025, 19(03): 157-164.
[4]	Zongheng Zhu, Zhihuo Zhang. Analysis of risk factors and construction of prediction model for contralateral central lymph node metastasis in papillary thyroid carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 337-340.
[5]	Xiaomei Qian, Hong Luo, Zhihui Li, Daijun Zhou, Dong Li. Logistic analysis of high-risk factors for primary liver cancer complicating hepatitis b-related liver cirrhosis in 76 cases [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 251-253.
[6]	Xiaoling Hua, Mengxin Gao, Yuan Chen, Chao Cai, Yongda Liu, Hongling Sun. Progress of reconstruction of benign ureteric stricture and current situation of reoperation [J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(03): 377-383.
[7]	Lili Zhang, Zhihai Han, Chunyang Zhang, Wei Chen, Yixin Kang, Yan Zhang, Jiguang Meng, Yiwei Ding, Jing Ding, Junchang Cui. Analysis of risk factors for progression and development of a predictive model in Fibrotic CTD-ILD [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(03): 434-441.
[8]	Jicai Wang, Guangquan Zhang, Fenfang Wu, Xianjie Shi. Mendelian randomization analysis of causality between Crohn’s disease and nonalcoholic fatty liver disease [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(04): 601-608.
[9]	Liyu Yang, Xinyang Liu, Yongqi Lei, Xuehong Tie, Yu Liu, Yingjian Liang. Risk factors, prevention and treatment of subcutaneous emphysema in laparoscopic surgery [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(04): 636-639.
[10]	Yan Zhou, Zeyang Zhou, Xinmeng Cheng, Yue'e He, Xiangyong Li, Yong Wu. Construction and validation of an early stoma complication prediction model for colorectal cancer patients [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2025, 14(03): 242-250.
[11]	Qingyuan Kang, Keshi Zhang, Wentao Xiao, Peisen Xie, Liguang Dong, Ping Yuan, Zhenpeng Guan. Prevalence and risk factors of knee osteoarthritis in active steelworkers [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(04): 248-255.
[12]	Shuangxing Wang, Yongjie Wu, Bing Meng, Hongtao Zhang, Dan Wei, Hui Zhang, Mei Diao. Risk factors for delayed postoperative recovery in infants with non-restrictive ventricular septal defect [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(03): 188-193.
[13]	Li Ma, Wenhua Liu, Dan Liu, Xiaotong Wang, Weiwan Kang, Yi Zhang, Xuejiao Wang. Pathogens and risk factors of peritoneal dialysis-associated peritonitis in patients with end-stage renal disease [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(03): 194-198.
[14]	Beibei Liu, Li Yi, Yingying Zhao, Honglin Liu, Yongbo Zhang. Characterization of concomitant extracranial and intracranial atherosclerotic lesions in high-risk coronary heart disease patients [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2025, 19(03): 184-190.
[15]	Weiwei Zhao, Ji Li, Hao Jiao, Xiaoxuan Liu, Yuhua Zhao. Comparative analysis of risk factors in patients with cerebrovascular diseases in Beijing and Xizang population [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2025, 19(03): 191-197.

Please choose a citation manager

Content to export